Doctor profile · Federal record
Dr. Christopher Laganke, MD
Neurology Physician (CMS: Neurology) · Cullman, AL
- NPI 1811931546
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 36 yrs in practice
- Male
- No sanctions
Practice & contact
- Primary practice
-
1809 Kress Street
Cullman, AL 35058
(256) 739-1210 - Mailing address
-
Po Box 870
Cullman, AL 350560870
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Alabama #16117
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1811931546. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
214,240
Distinct HCPCS
10
Medicare allowed
$5,601,371
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2323 |
Injection, natalizumab, 1 mg | 130,200 | 49 | $23 | |
J2350 |
Injection, ocrelizumab, 1 mg | 27,000 | 26 | $55 | |
J0585 |
Injection, onabotulinumtoxina, 1 unit | 25,880 | 41 | $5 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 18,710 | 23 | $42 | |
J0586 |
Injection, abobotulinumtoxina, 5 units | 8,220 | 11 | $8 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 825 | 91 | $56 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 762 | 455 | $111 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 719 | 16 | $0 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 649 | 34 | $18 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 438 | 46 | $6 |
In context: peer comparison
Among 4 peers in Cullman Neurology Physician, average services per provider: 6,142. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$98,637
Transactions
289
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Emd Serono, INC. | 31 | $26,865.26 | |
| Biogen, INC. | 40 | $25,414.07 | |
| Ares Trading Sa | 1 | $18,417.00 | |
| Tg Therapeutics, INC. | 19 | $17,057.92 | |
| Genzyme Corporation | 8 | $7,348.27 | |
| Ucb, INC. | 58 | $711.39 | |
| Celgene Corporation | 17 | $611.99 | |
| Alexion Pharmaceuticals, INC. | 8 | $268.74 | |
| Novartis Pharmaceuticals Corporation | 18 | $249.05 | |
| Argenx US, INC. | 12 | $196.75 | |
| Abbvie INC. | 19 | $191.73 | |
| Eisai INC. | 8 | $178.49 | |
| Genentech USA, INC. | 11 | $169.66 | |
| Corium, LLC | 34 | $150.34 | |
| Neurocrine Biosciences, INC. | 5 | $135.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
16,736
Patients
2,613
Total drug cost
$1,605,300
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dextroamphetamine-Amphetamine (Dextroamphetamine/Amphetamine) | Brand | 2,655 | 376 | $126,969 |
| Baclofen | Generic | 1,957 | 392 | $56,664 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 1,546 | 175 | $39,172 |
| Lacosamide | Generic | 1,464 | 248 | $271,294 |
| Alprazolam | Generic | 1,384 | 186 | $9,585 |
| Gabapentin | Generic | 1,250 | 203 | $27,010 |
| Clonazepam | Generic | 1,185 | 162 | $11,141 |
| Vyvanse (Lisdexamfetamine Dimesylate) | Brand | 858 | 140 | $339,399 |
| Dalfampridine ER (Dalfampridine) | Brand | 849 | 136 | $408,566 |
| Tizanidine Hcl | Generic | 770 | 120 | $16,262 |
Hospital affiliations
Frequently asked questions
What is Dr. Christopher Laganke's medical specialty?
Dr. Christopher Laganke practices Neurology Physician in Cullman, AL.
Where does Dr. Christopher Laganke practice?
Dr. Christopher Laganke practices at 1809 Kress Street, Cullman, AL 35058. Office phone: 2567391210.
What is Dr. Christopher Laganke's NPI?
Dr. Christopher Laganke's National Provider Identifier (NPI) is 1811931546, issued by NPPES.
Does Dr. Christopher Laganke accept Medicare assignment?
Yes. Dr. Christopher Laganke accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Laganke commonly perform?
Top Medicare-reported procedures in 2023: Injection, natalizumab, 1 mg (HCPCS J2323); Injection, ocrelizumab, 1 mg (HCPCS J2350); Injection, onabotulinumtoxina, 1 unit (HCPCS J0585). Source: CMS Medicare Physician & Other Practitioners file.